You are here : Home > Scientific Specialties > Formulation
Formulation Services

In addition to pre-formulation services, solid state and crystallization services, and analytical support for physico-chemical characterization and method validation, CARBOGEN AMCIS offers a complete range of formulation services for parenteral APIs and highly-potent APIs. Our formulation and aseptic drug products services are performed at our Riom, France, site, which is exclusively dedicated to the development of parenteral products and to the fast supply of batches for clinical trials.

CARBOGEN AMCIS develops sterile and pyrogen-free parenteral formulations for preclinical and clinical trials. We have over 10 years of experience with injectables, liquids and semi-solid pharmaceutical forms for a wide range of drugs, including oncology and metabolic disorder therapeutics. We can safely handle material of the highest occupational exposure band, including cytostatics and cytotoxics.

Our offerings include:

  • Formulation of new products
  • Optimisation of existing formulations
  • Development and optimisation of lyophilization cycles
  • Development and validation of analytical methods
  • Pre-stability studies and ICH stability studies
  • Up-scaling of formula and process

Highlights of key facilities and instrumentation:

  • 2.4 square meter Glovebox for highly-potent compounds
  • 0.6 square meter Lyophilizer Telstar Lyobeta 20
  • Array of analytical equipment

Formulation img1 Formulation img2


16 February 2018
CARBOGEN AMCIS Announces a Successful Swissmedic Inspection of its Site in Vionnaz, Switzerland

11 October 2017
CARBOGEN AMCIS Announces a Successful FDA Inspection of its Headquarters Site in Bubendorf, Switzerland

21 July 2017
CARBOGEN AMCIS Sites at Bubendorf, Aarau and Neuland in Switzerland Successfully Pass Swissmedic Inspection

DCAT week

World ADC Berlin